Phase II study of adjuvant chemotherapy with paclitaxel and nedaplatin for FIGO stage IB-IIA uterine cervical cancer with lymph node metastasis following radical hysterectomy: A Kansai Clinical Oncology Group study (KCOG-G1101).

被引：0
|
作者：
Takekuma, Munetaka
Kasamatsu, Yuka
Nishio, Shin
Omi, Hideo
Tabata, Tsutomu
Takei, Yuji
Nasu, Kaei
Takahashi, Yoshiyuki
Toyoda, Shinji
Ichikawa, Yoshikazu
Arakawa, Atsushi
Ito, Fuminori
Tsubamoto, Hiroshi
Mori, Taisuke
Ito, Kimihiko
机构：
[1] Natl Hosp Org Shikoku Canc Ctr, Dept Gynecol Oncol, Shizuoka, Japan
[2] Kurume Univ, Dept Obstet & Gynecol, Sch Med, Kurume, Fukuoka, Japan
[3] Iwate Med Univ, Dept Obstet & Gynecol, Sch Med, Morioka, Iwate, Japan
[4] Mie Univ Hosp, Dept Obstet & Gynecol, Tsu, Mie, Japan
[5] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan
[6] Oita Univ, Dept Obstet & Gynecol, Fac Med, Yufu, Japan
[7] Okinawa Chubu Hosp, Dept Obstet & Gynecol, Uruma, Okinawa, Japan
[8] Nara Prefecture Gen Med Ctr, Dept Obstet & Gynecol, Nara, Japan
[9] Japanese Red Cross Shizuoka Hosp, Dept Obstet & Gynecol, Shizuoka, Japan
[10] Nagoya City Univ Hosp, Dept Obstet & Gynecol, Nagoya, Aichi, Japan
[11] Nara Med Univ, Dept Obstet & Gynecol, Kashihara, Nara, Japan
[12] Hyogo Coll Med, Dept Obstet & Gynecol, Nishinomiya, Hyogo, Japan
[13] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Obstet & Gynecol, Kyoto, Japan
[14] Kansai Rosai Hosp, Dept Obstet & Gynecol, Amagasaki, Hyogo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e17024
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17024
引用
收藏
页数：4
相关论文
共 16 条
  • [1] Phase II study of adjuvant chemotherapy with paclitaxel and nedaplatin for uterine cervical cancer with lymph node metastasis
    Takekuma, Munetaka
    Shimokawa, Mototsugu
    Nishio, Shin
    Omi, Hideo
    Tabata, Tsutomu
    Takei, Yuji
    Nasu, Kaei
    Takahashi, Yoshiyuki
    Toyota, Shinji
    Ichikawa, Yoshikazu
    Arakawa, Atsushi
    Ito, Fuminori
    Tsubamoto, Hiroshi
    Mori, Taisuke
    Hirashima, Yasuyuki
    Ito, Kimihiko
    CANCER SCIENCE, 2018, 109 (05) : 1602 - 1608
  • [2] Multi-institutional phase II study of neoadjuvant irinotecan and nedaplatin followed by radical hysterectomy and the adjuvant chemotherapy for locally advanced, bulky uterine cervical cancer: A Kansai Clinical Oncology Group study (KCOG-G1201)
    Mori, Taisuke
    Makino, Hiroshi
    Okubo, Tomoharu
    Fujiwara, Yoichiro
    Sawada, Morio
    Kuroboshi, Haruo
    Tsubamoto, Hiroshi
    Murakoshi, Homare
    Motohashi, Takashi
    Kitawaki, Jo
    Ito, Kimihiko
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2019, 45 (03) : 671 - 678
  • [3] Phase II trial of paclitaxel and nedaplatin in patients with advanced/recurrent uterine cervical cancer: A Kansai Clinical Oncology Group study
    Takekuma, Munetaka
    Hirashima, Yasuyuki
    Ito, Kimihiko
    Tsubamoto, Hiroshi
    Tabata, Tsutomu
    Arakawa, Atsushi
    Itani, Yoshio
    Furukawa, Naoto
    Murakoshi, Homare
    Takeuchi, Satoshi
    GYNECOLOGIC ONCOLOGY, 2012, 126 (03) : 341 - 345
  • [4] Phase II trial of paclitaxel and nedaplatin in patients with advanced/recurrent uterine cervical cancer: A Kansai Clinical Oncology Group study.
    Takekuma, M.
    Hirashima, Y.
    Ito, K.
    Tsubamoto, H.
    Tabata, T.
    Arakawa, A.
    Itani, Y.
    Furukawa, N.
    Murakoshi, H.
    Takeuchi, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] A RANDOMIZED TRIAL OF ADJUVANT CHEMOTHERAPY AFTER RADICAL HYSTERECTOMY IN STAGE IB-IIA CERVICAL-CANCER PATIENTS WITH PELVIC LYMPH-NODE METASTASES
    TATTERSALL, MHN
    RAMIREZ, C
    COPPLESON, M
    GYNECOLOGIC ONCOLOGY, 1992, 46 (02) : 176 - 181
  • [6] Retrospective analysis of prognosis using the Gynecology Oncology Group score of stage IB-IIA node negative uterine cervical cancer after radical hysterectomy and trachelectomy
    Kinjo, Yasuyuki
    Matsuura, Yusuke
    Ohguri, Takayuki
    Aoyama, Yoko
    Murakami, Midori
    Hoshino, Kaori
    Harada, Hiroshi
    Ueda, Taeko
    Kurita, Tomoko
    Kagami, Seiji
    Yoshino, Kiyoshi
    MOLECULAR AND CLINICAL ONCOLOGY, 2022, 16 (06)
  • [7] Clinical Role of Adjuvant Chemotherapy after Radical Hysterectomy for FIGO Stage IB-IIA Cervical Cancer: Comparison with Adjuvant RT/CCRT Using Inverse-Probability-of-Treatment Weighting
    Jung, Phill-Seung
    Kim, Dae-Yeon
    Lee, Shin-Wha
    Park, Jeong-Yeol
    Suh, Dae-Shik
    Kim, Jong-Hyeok
    Kim, Yong-Man
    Kim, Young-Tak
    Nam, Joo-Hyun
    PLOS ONE, 2015, 10 (07):
  • [8] Adjuvant chemotherapy with paclitaxel and cisplatin after radical hysterectomy in patients with intermediate- and high-risk stage IB-IIA cervical cancer: A matched case-control study
    Kim, J.
    Chun, K.
    Kim, D.
    Kim, J.
    Kim, Y.
    Kim, Y.
    Nam, J.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S44 - S45
  • [9] Effect of the Number of Removed Lymph Nodes on Survival in Patients with FIGO Stage IB-IIA Cervical Squamous Cell Carcinoma following Open Radical Hysterectomy with Pelvic Lymphadenectomy: A Retrospective Cohort Study
    Guo, Qinhao
    Wu, Yong
    Wen, Hao
    Ju, Xingzhu
    Wu, Xiaohua
    JOURNAL OF ONCOLOGY, 2021, 2021
  • [10] Type II Radical Hysterectomy and Adjuvant Therapy for Pelvic Lymph Node Metastasis With Stage IB-IIB Cervical Carcinoma: A Retrospective Study of 288 Patients
    Zheng, Min
    Huang, Long
    Liu, Ji-Hong
    Xiong, Ying
    Li, Jun-Dong
    Huang, Xin
    He, Li
    Ren, Yu-Feng
    Wang, Hui-Yun
    JOURNAL OF SURGICAL ONCOLOGY, 2011, 104 (05) : 480 - 485
12